345 PARK AVENUE SOUTH, NEW YORK, NY
Market cap: $203.4M (12/18/2025)
Price: $5.27
Protara Therapeutics Completes $5.75 Public Offering of 13,043,479 Shares
Protara Therapeutics Enters Underwriting Agreement for $75 Million Offering
ADVANCED - 2: Preliminary Efficacy and Safety Data in BCG - naïve Participants with High - grade Non - muscle Invasive Bladder Cancer
Announces Positive Interim Results Demonstrating Robust Responses in the Ongoing Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations
Announces Third Quarter 2025 Financial Results and Provides Business Update
Announces Second Quarter 2025 Financial Results and Provides Business Update
Submission of Matters to a Vote of Security Holders
Announces First Quarter 2025 Financial Results and Provides Business Update
Q3
Q2
Q1
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Prospectus filed pursuant to Rule 424(b)(7)